Related Experiment Video
Updated: Jul 5, 2026
05:03
Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography
Published on: December 27, 2024
Bilirubin in clinical practice: a review
1Laboratory of Hepatology, University Hospital Gasthuisberg, Leuven, Belgium. Johan.Fevery@med.kuleuven.be
Summary
Bilirubin, a compound in the body, can be toxic but also offers protection against heart disease and tumors. This study explores conditions that elevate serum bilirubin levels and their underlying mechanisms.
Area of Science:
- Biochemistry
- Physiology
- Pathology
Background:
- Bilirubin is an endogenous compound with a dual role in human health.
- While toxic at high levels, mild unconjugated hyperbilirubinemia may confer protective effects.
- Elevated serum bilirubin is observed in various clinical contexts.
Purpose of the Study:
- To discuss clinical conditions associated with enhanced serum bilirubin levels.
- To outline the mechanisms underlying bilirubin level alterations.
- To explore the protective and toxic effects of bilirubin.
Main Methods:
- Literature review of clinical conditions and bilirubin metabolism.
- Analysis of biochemical pathways involved in bilirubin production and conjugation.
- Discussion of epidemiological and clinical data on bilirubin levels.
Main Results:
- Identified diverse clinical conditions leading to increased serum bilirubin.
- Outlined mechanisms including impaired conjugation, increased production, and altered excretion.
- Highlighted the potential cardioprotective and anti-tumorigenic effects of mild hyperbilirubinemia.
Conclusions:
- Serum bilirubin levels are significantly influenced by various physiological and pathological states.
- Understanding bilirubin's complex role is crucial for clinical assessment and therapeutic strategies.
- Further research into bilirubin's protective mechanisms warrants investigation.
Related Concept Videos
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:14Changes in Skin Color: Clinical Perspectives
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:22Lifecycle of Erythrocytes
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...